Physician profile
James Scott Aston
NPI 1578856639
$361.96
in general payments reported to CMS, 2019-2025
12 companies · $58.96 in 2025
The $58.96 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.00 · 2020: $19.48 · 2021: $113 · 2022: $20.04 · 2023: $56.59 · 2024: $53.22 · 2025: $58.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $168.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $69.77 | 2021-2025 | Nexplanon |
| Janssen Biotech, INC. | $56.59 | 2021 | |
| Intuitive Surgical, INC. | $44.80 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.00 | 2019 | |
| Glaxosmithkline, LLC. | $36.46 | 2021-2024 | Shingrix |
| Sun Pharmaceutical Industries INC. | $19.48 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $19.19 | 2025 | Rexulti |
| Abbvie INC. | $16.26 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $15.63 | 2024 | Crysvita |
| Medtronic, INC. | $14.79 | 2025 | Inceptiv |
| Sanofi-Aventis U.S. LLC | $14.48 | 2025 | |
| Nestle Healthcare Nutrition INC. | $13.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Aston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.